Selected Financial Data
since 2005
Income Statement
Cytokinetics Inc., selected items from income statement, long-term trends
US$ in thousands
| 12 months ended: | Revenues | Operating income (loss) | Net income (loss) |
|---|---|---|---|
| Dec 31, 2022 | 94,588) | (324,202) | (388,955) |
| Dec 31, 2021 | 70,428) | (186,313) | (215,314) |
| Dec 31, 2020 | 55,828) | (93,943) | (127,290) |
| Dec 31, 2019 | 26,868) | (98,867) | (121,692) |
| Dec 31, 2018 | 31,501) | (88,916) | (106,289) |
| Dec 31, 2017 | 13,368) | (113,396) | (127,790) |
| Dec 31, 2016 | 106,407) | 18,687) | 16,453) |
| Dec 31, 2015 | 28,658) | (37,407) | (37,501) |
| Dec 31, 2014 | 46,940) | (14,754) | (14,646) |
| Dec 31, 2013 | 30,648) | (33,894) | (33,717) |
| Dec 31, 2012 | 7,559) | (40,457) | (40,370) |
| Dec 31, 2011 | 4,000) | (47,964) | (47,860) |
| Dec 31, 2010 | 2,577) | (49,635) | (49,287) |
| Dec 31, 2009 | 81,538) | 26,095) | 24,544) |
| Dec 31, 2008 | 12,420) | (59,079) | (56,374) |
| Dec 31, 2007 | 13,622) | (56,487) | (48,894) |
| Dec 31, 2006 | 3,127) | (61,338) | (57,115) |
| Dec 31, 2005 | 8,912) | (44,633) | (42,252) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Assets
Cytokinetics Inc., selected items from assets, long-term trends
US$ in thousands
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2022 | 795,186) | 1,014,775) |
| Dec 31, 2021 | 535,672) | 841,319) |
| Dec 31, 2020 | 474,221) | 533,803) |
| Dec 31, 2019 | 233,752) | 289,814) |
| Dec 31, 2018 | 207,674) | 211,178) |
| Dec 31, 2017 | 274,295) | 294,810) |
| Dec 31, 2016 | 158,633) | 170,142) |
| Dec 31, 2015 | 113,107) | 115,237) |
| Dec 31, 2014 | 131,131) | 132,968) |
| Dec 31, 2013 | 79,338) | 83,188) |
| Dec 31, 2012 | 76,427) | 77,551) |
| Dec 31, 2011 | 51,140) | 52,773) |
| Dec 31, 2010 | 73,498) | 77,992) |
| Dec 31, 2009 | 116,921) | 122,599) |
| Dec 31, 2008 | 58,910) | 87,454) |
| Dec 31, 2007 | 122,016) | 155,370) |
| Dec 31, 2006 | 153,621) | 169,516) |
| Dec 31, 2005 | 78,864) | 91,461) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Cytokinetics Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in thousands
| Current liabilities | Total liabilities | Debt | Stockholders’ equity (deficit) | |
|---|---|---|---|---|
| Dec 31, 2022 | 84,617) | 1,122,675) | 609,618) | (107,900) |
| Dec 31, 2021 | 71,860) | 597,456) | 142,838) | 243,863) |
| Dec 31, 2020 | 31,199) | 420,420) | 135,713) | 113,383) |
| Dec 31, 2019 | 26,023) | 300,751) | 129,257) | (10,937) |
| Dec 31, 2018 | 22,194) | 185,244) | 42,413) | 25,934) |
| Dec 31, 2017 | 32,444) | 184,968) | 31,777) | 109,842) |
| Dec 31, 2016 | 33,258) | 75,781) | 29,881) | 94,361) |
| Dec 31, 2015 | 31,649) | 46,647) | 14,639) | 68,590) |
| Dec 31, 2014 | 23,855) | 40,904) | —) | 92,064) |
| Dec 31, 2013 | 26,704) | 28,746) | —) | 54,442) |
| Dec 31, 2012 | 7,105) | 7,466) | —) | 70,085) |
| Dec 31, 2011 | 4,592) | 4,595) | 152) | 48,178) |
| Dec 31, 2010 | 7,324) | 7,476) | 985) | 70,516) |
| Dec 31, 2009 | 20,186) | 21,171) | 2,601) | 101,428) |
| Dec 31, 2008 | 22,877) | 37,688) | 4,640) | 49,766) |
| Dec 31, 2007 | 26,448) | 55,454) | 8,689) | 99,916) |
| Dec 31, 2006 | 26,393) | 63,203) | 10,835) | 106,313) |
| Dec 31, 2005 | 11,264) | 17,900) | 9,362) | 73,561) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Cash Flow Statement
Cytokinetics Inc., selected items from cash flow statement, long-term trends
US$ in thousands
| 12 months ended: | Net cash provided by (used in) operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
|---|---|---|---|
| Dec 31, 2022 | (299,516) | (262,134) | 516,166) |
| Dec 31, 2021 | (142,522) | (147,777) | 319,980) |
| Dec 31, 2020 | 8,943) | (196,515) | 234,124) |
| Dec 31, 2019 | (90,907) | (74,707) | 159,791) |
| Dec 31, 2018 | (101,215) | 5,133) | 13,132) |
| Dec 31, 2017 | (101,759) | (65,828) | 225,919) |
| Dec 31, 2016 | 36,982) | (52,076) | 16,892) |
| Dec 31, 2015 | 4,883) | 16,063) | 23,915) |
| Dec 31, 2014 | (44,843) | (4,049) | 48,949) |
| Dec 31, 2013 | (7,718) | (1,519) | 14,488) |
| Dec 31, 2012 | (33,438) | (28,815) | 58,327) |
| Dec 31, 2011 | (45,595) | 25,301) | 21,613) |
| Dec 31, 2010 | (44,830) | 34,237) | 2,546) |
| Dec 31, 2009 | 8,416) | (53,480) | 28,806) |
| Dec 31, 2008 | (61,328) | (9,966) | (3,451) |
| Dec 31, 2007 | (3,005) | 45,462) | 34,720) |
| Dec 31, 2006 | (47,170) | (13,682) | 86,724) |
| Dec 31, 2005 | (39,484) | 34,492) | 5,446) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Per Share Data
Cytokinetics Inc., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2022 | -4.33 | -4.33 | 0.00 |
| Dec 31, 2021 | -2.80 | -2.80 | 0.00 |
| Dec 31, 2020 | -1.97 | -1.97 | 0.00 |
| Dec 31, 2019 | -2.11 | -2.11 | 0.00 |
| Dec 31, 2018 | -1.95 | -1.95 | 0.00 |
| Dec 31, 2017 | -2.59 | -2.59 | 0.00 |
| Dec 31, 2016 | 0.41 | 0.39 | 0.00 |
| Dec 31, 2015 | -0.97 | -0.97 | 0.00 |
| Dec 31, 2014 | -0.41 | -0.41 | 0.00 |
| Dec 31, 2013 | -1.24 | -1.24 | 0.00 |
| Dec 31, 2012 | -2.30 | -2.30 | 0.00 |
| Dec 31, 2011 | -4.30 | -4.30 | 0.00 |
| Dec 31, 2010 | -4.61 | -4.61 | 0.00 |
| Dec 31, 2009 | 2.57 | 2.54 | 0.00 |
| Dec 31, 2008 | -6.84 | -6.84 | 0.00 |
| Dec 31, 2007 | -6.18 | -6.18 | 0.00 |
| Dec 31, 2006 | -9.36 | -9.36 | 0.00 |
| Dec 31, 2005 | -8.88 | -8.88 | 0.00 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.